Debate: Albumin administration should be avoided in the critically ill. Critical care (London, England) [Crit Care] Journal article | | Title | Debate: Albumin administration should be avoided in the critically ill. | | Author(s) | Pulimood TB, Park GR | | Institution | John Farman Intensive Care Unit, Addenbrooke's Hospital, Hill's Road, Cambridge, UK. | | Source | Crit Care 2000; 4(3):151-5. | | MeSH | Albumins
Critical Illness
Evidence-Based Medicine
Humans
Infusions, Intravenous
Meta-Analysis
Metabolic Clearance Rate
Patient Selection
Practice Guidelines
Treatment Outcome
| | Abstract | The benefit of albumin administration in the critically ill patient is unproven. Epidemiological evidence suggests that there is an increase in death among patients with burns, hypoalbuminaemia, and hypotension treated with human albumin solution (HAS). In critical illness, hypoalbuminaemia is a result of transcapillary leak, decreased synthesis, large volume body fluid losses, and dilution caused by fluid resuscitation. When treating patients with hypoalbuminaemia, efforts must be centred around correction of the underlying disorder rather than reversal of hypoalbuminaemia. Problems with using albumin arise because it is an expensive blood product, and can result in systemic changes that include cardiovascular, haematological, renal, pulmonary, and immunological effects. | | Language | eng | | Pub Type(s) | Journal Article
Review
| | PubMed ID | 11211856 |
|
|
| |
Advertise on this site.
| | |
|
